Kein Vorteil durch Addition von Radium-223 zu Abirateronacetat
Crossref DOI link: https://doi.org/10.1007/s15004-019-6556-3
Published Online: 2019-06-14
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schalhorn, Andreas
Text and Data Mining valid from 2019-06-01
Version of Record valid from 2019-06-01
Article History
First Online: 14 June 2019